Trupti Sheth

2 Patents

• US125514852026

  Topical Formulations of Ruxolitinib with an Organic Amine Ph Adjusting Agent for Treatment of Skin Diseases

  Incyte Corporation

  0 cites
• US121510262024

  Sustained Release Dosage Forms for a JAK1 Inhibitor

  Incyte Holdings Corporation

  0 cites